How to Design an Inhaled Drug: CHF-6523.

J Med Chem

Medicinal Chemistry, Research and Early Development, Respiratory & Immunology, BioPharmaceuicals R&D, AstraZeneca Gothenburg, Pepparedsleden, SE-431 83 Mölndal, Sweden.

Published: January 2025

AI Article Synopsis

Article Abstract

Inhalation provides an opportunity to target drugs to the lung, potentially improving efficacy and safety margins for the treatment of respiratory conditions. The discovery of inhaled medicines is a specialized endeavor and has different challenges to medicinal chemistry for oral drugs. The appearance of a successful campaign delivering an inhaled PI3Kδ inhibitor is therefore an opportunity to highlight how a team can address the challenges involved in the identification of such a compound. This Viewpoint seeks to highlight a great example of medicinal chemistry in the inhaled space.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.4c03130DOI Listing

Publication Analysis

Top Keywords

medicinal chemistry
8
design inhaled
4
inhaled drug
4
drug chf-6523
4
chf-6523 inhalation
4
inhalation opportunity
4
opportunity target
4
target drugs
4
drugs lung
4
lung improving
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!